- Home
- LIQT vs SPRB Comparison
LIQT vs SPRB Comparison
Compare LIQT & SPRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- SPRB
- Stock Information
- Founded
- LIQT 2004
- SPRB 2014
- Country
- LIQT Denmark
- SPRB United States
- Employees
- LIQT N/A
- SPRB N/A
- Industry
- LIQT Industrial Machinery/Components
- SPRB Medicinal Chemicals and Botanical Products
- Sector
- LIQT Technology
- SPRB Health Care
- Exchange
- LIQT Nasdaq
- SPRB Nasdaq
- Market Cap
- LIQT 16.9M
- SPRB 15.7M
- IPO Year
- LIQT N/A
- SPRB 2020
- Fundamental
- Price
- LIQT $1.61
- SPRB $0.42
- Analyst Decision
- LIQT Strong Buy
- SPRB Hold
- Analyst Count
- LIQT 2
- SPRB 7
- Target Price
- LIQT $4.60
- SPRB $2.17
- AVG Volume (30 Days)
- LIQT 4.1K
- SPRB 417.1K
- Earning Date
- LIQT 03-20-2025
- SPRB 03-12-2025
- Dividend Yield
- LIQT N/A
- SPRB N/A
- EPS Growth
- LIQT N/A
- SPRB N/A
- EPS
- LIQT N/A
- SPRB N/A
- Revenue
- LIQT $15,128,295.00
- SPRB $7,101,000.00
- Revenue This Year
- LIQT N/A
- SPRB N/A
- Revenue Next Year
- LIQT $31.19
- SPRB N/A
- P/E Ratio
- LIQT N/A
- SPRB N/A
- Revenue Growth
- LIQT N/A
- SPRB N/A
- 52 Week Low
- LIQT $1.51
- SPRB $0.34
- 52 Week High
- LIQT $3.42
- SPRB $5.95
- Technical
- Relative Strength Index (RSI)
- LIQT 39.80
- SPRB 58.94
- Support Level
- LIQT $1.64
- SPRB $0.38
- Resistance Level
- LIQT $1.66
- SPRB $0.42
- Average True Range (ATR)
- LIQT 0.08
- SPRB 0.03
- MACD
- LIQT -0.01
- SPRB 0.00
- Stochastic Oscillator
- LIQT 12.12
- SPRB 69.77
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).